Market Snapshot:
Bio Mems also known as a study of biomolecules, cells and tissue using micro fabricated systems, are aqueous microfluidic systems. BioMEMS Microfluidics as a science includes traditional MEMS/microstructure technology (MST) and an expansion into a host of new polymer materials, microfluidic physics, surface chemistries and modification, soft fabrication techniques (including polymers and biologic components), biocompatibility and cost effective solutions to biomedical problems. BioMEMS Microfluidics is also the quintessential science for genomics, the study of sets of genes, gene products and their interactions and proteomics, the study of proteins and the expression of genes in health and disease. Applications include diagnostics, health screening, individualized treatment, drug-delivery systems, and tissue engineering and minimally invasive procedures.
Highlights from Bio Mems Microfluidics Market Study
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
The key Players profiled in the report are Danaher Corporation (United States), PerkinElmer, Inc (United States), All Sensors Corporation (United States), TE Connectivity (United States), Abbott Diagnostics (United States), Nova Biomedical (United States), Boston Scientific (United States), ROCHE (Switzerland), Becton, Dickinson (United States) and Dolomite Bio (United Kingdom). Additionally, other players that are part of this comprehensive study are CellBio Inc. (United States).
Geographic Breakdown and Segment Analysis
The Global Bio Mems Microfluidics market presents a comprehensive analysis of the Bio Mems Microfluidics market by product type (Biomedical MEMS and Biotechnological MEMS), by end-user/application (Capillary Electrophoresis, Isoelectric Focusing, DNA Analysis, Cell Patterning. and Other), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Bio Mems Microfluidics industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest.
For instance, while the holds majority of market share of the Bio Mems Microfluidics market
Analyst at AMA have segmented the market study of Global Bio Mems Microfluidics market by Type, Application and Region.
Influencing Trend:
Innovation Of New Microfabrication 3D Printing Technology
Market Growth Drivers:
Demand In Study Of Antibiotic Drug-Resistant Bacteria And Nanoparticle Transport In Blood, Demand In Diagnostic Use Of Cancer And Pathogen Detections and Surge In Demand In Biopharmaceutical Production
Challenges:
Limited Technology Available for Bio Mems Microfluidics Fabrications, Fluctuation in Prices of Raw Materials and Low Penetration in Developing Regions
Restraints:
Lack of Proper Engineers and Skilled Employees for Bio-Mems, Relatively More Economical Due To Batch Fabrication And High-Throughput, High Reagent Consumption Associated with Bio Mems Microfluidics and Complex Operational Control and Chip Design of Bio Mems Microfluidics
Opportunities:
Growing Healthcare Infrastructure and Biotechnology and Technological Advancements in Clinical Research
Market Developments Activities:
On 26 September 2021, Connectors and sensors specialist TE Connectivity has acquired three companies focused on microfluidic cartridge and blister reagent package development, usability testing, clinical research, and manufacturing.
Regulatory Insights:
Manufacturers (both domestic and foreign) and initial distributors (importers) of medical devices must register their establishments with the FDA. All establishment registrations must be submitted electronically unless a waiver has been granted by FDA. All registration information must be verified annually between October 1st and December 31st of each year. In addition to registration, foreign manufacturers must also designate a U.S. Agent. Beginning October 1, 2007, most establishments are required to pay an establishment registration fee.
The market for Bio Mems Microfluidics is highly competitive with several global as well as local players in the market. The global players are trying various strategies such as product innovation and using various marketing strategies to gain a higher market share.
Key Target Audience
Bio Mems Microfluidics Manufacturers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others